CMS’s new national payment rate and unique reimbursement codes signal a transformative shift in radiotherapy reimbursement, removing barriers to the clinical adoption of RefleXion’s SCINTIX biology-guided radiotherapy. The breakthrough approach, utilizing emissions from cancer…
Continue Reading
Are you a healthcare startup in health tech, diagnostics, medtech, or biotech? If so, you should consider applying to the MedCity News startup pitch contest at the INVEST conference at the Ritz Carlton in…
Continue Reading
What You Should Know: Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, and Quest Diagnostics, the nation’s leading provider of diagnostic information services, today announced a collaboration involving Ultima’s next generation sequencing…
Continue Reading
What You Should Know:
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionise healthcare and improve the human condition using molecular science…
Continue Reading
Penn Medicine’s iStar emerges as a game-changing AI tool, developed by Perelman School of Medicine experts. This revolutionary application, short for Inferring Super-Resolution Tissue Architecture, presents a paradigm shift in oncology diagnostics. iStar delves…
Continue Reading
Chaim Linhart, Chaim, Co-founder and CTO at Ibex Medical Analytics
Artificial intelligence (AI) technology is set to transform the field of diagnostics, similar to how X-rays and genetic tests revolutionized healthcare in the past. Reshaping…
Continue Reading
The application, known as iStar, was created by Perelman School of Medicine researchers to give clinicians more insights into gene activities in medical images and, potentially, help them diagnose cancers that might have otherwise…
Continue Reading
ConcertAI will Invest in CancerLinQ to Provide its Members with Upgraded Quality Reporting, Industry-Leading Real-World Data, and AI-Powered Solutions for Accelerated Clinical Trials in a Multi-Year Cooperation Agreement with ASCO
ConcertAI today announced the acquisition…
Artificial General Intelligence (AGI) is reshaping radiation oncology, boosting precision and efficiency. AGI models like GPT-4, PaLM 2, and LVMs such as SAM excel in auto-segmentation, treatment planning, and outcome prediction. Their few-shot and…
Continue Reading
Greater use of digital solutions could relieve the enormous pressure on cancer services, improve outcomes and personalise care, says consultant oncologist Penny KechagioglouWith around 3 million people living with cancer in the UK –…
Continue Reading
